BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$5.32B |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
+$316M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$157M |
| 4 |
CGI
GIB
|
+$140M |
| 5 |
PPG Industries
PPG
|
+$114M |
Top Sells
| 1 |
Canadian National Railway
CNI
|
+$750M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$484M |
| 3 |
Apple
AAPL
|
+$298M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$260M |
| 5 |
McDonald's
MCD
|
+$169M |
Sector Composition
| 1 | Technology | 8.58% |
| 2 | Financials | 8.18% |
| 3 | Healthcare | 5.72% |
| 4 | Consumer Discretionary | 5.19% |
| 5 | Communication Services | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Sony
SONY
$175B
| $313K | ﹤0.01% |
63,880
+9,005
| +16% | +$44.1K |
|
1602
iShares MSCI France ETF
EWQ
$391M
| $313K | ﹤0.01% |
+13,000
| New | +$313K |
|
|
FNGN
1603
DELISTED
Financial Engines, Inc.
FNGN
| $313K | ﹤0.01% |
10,613
+6,299
| +146% | +$186K |
|
1604
PENN Entertainment
PENN
$2.86B
| $313K | ﹤0.01% |
18,633
+9,925
| +114% | +$167K |
|
1605
Caleres
CAL
$503M
| $311K | ﹤0.01% |
+10,187
| New | +$311K |
|
1606
Chord Energy
CHRD
$5.96B
| $310K | ﹤0.01% |
35,690
-9,059
| -20% | -$78.6K |
|
1607
LCI Industries
LCII
$2.43B
| $310K | ﹤0.01% |
5,668
+3,017
| +114% | +$165K |
|
|
TWO
1608
Two Harbors Investment
TWO
$1.05B
| $309K | ﹤0.01% |
4,382
-3,844
| -47% | -$271K |
|
|
VRTU
1609
DELISTED
Virtusa Corporation
VRTU
| $309K | ﹤0.01% |
6,018
+3,451
| +134% | +$177K |
|
1610
La-Z-Boy
LZB
$1.39B
| $309K | ﹤0.01% |
11,625
+5,957
| +105% | +$158K |
|
1611
ATI
ATI
$10.5B
| $308K | ﹤0.01% |
21,747
-10,424
| -32% | -$148K |
|
1612
Pacira BioSciences
PCRX
$1.22B
| $308K | ﹤0.01% |
7,492
+4,460
| +147% | +$183K |
|
1613
Nexstar Media Group
NXST
$6.27B
| $308K | ﹤0.01% |
6,502
+3,825
| +143% | +$181K |
|
1614
Sanofi
SNY
$115B
| $307K | ﹤0.01% |
6,474
+923
| +17% | +$43.8K |
|
1615
AMN Healthcare
AMN
$699M
| $307K | ﹤0.01% |
10,231
+5,260
| +106% | +$158K |
|
1616
CONMED
CNMD
$1.64B
| $307K | ﹤0.01% |
6,428
+3,567
| +125% | +$170K |
|
|
ACHN
1617
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $306K | ﹤0.01% |
44,307
+24,527
| +124% | +$169K |
|
1618
Plexus
PLXS
$3.73B
| $304K | ﹤0.01% |
7,890
+2,284
| +41% | +$88.1K |
|
1619
LiveRamp
RAMP
$1.73B
| $304K | ﹤0.01% |
15,382
+9,461
| +160% | +$187K |
|
1620
Ligand Pharmaceuticals
LGND
$3.23B
| $304K | ﹤0.01% |
5,687
+3,347
| +143% | +$179K |
|
|
CHSP
1621
DELISTED
Chesapeake Lodging Trust
CHSP
| $303K | ﹤0.01% |
11,640
+2,868
| +33% | +$74.7K |
|
1622
Eagle Bancorp
EGBN
$615M
| $303K | ﹤0.01% |
6,659
+4,068
| +157% | +$185K |
|
1623
Essential Utilities
WTRG
$10.7B
| $303K | ﹤0.01% |
11,437
-376,052
| -97% | -$9.95M |
|
|
LTXB
1624
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $303K | ﹤0.01% |
9,929
+5,969
| +151% | +$182K |
|
1625
Stellantis
STLA
$26.9B
| $302K | ﹤0.01% |
+35,117
| New | +$302K |
|